BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2013
View Archived Issues
Several microRNAs elevated in serum after ischemic stroke
Read More
Recombinant allergen therapy for patients with birch pollen allergy
Read More
CDK4/6 inhibitor LY-2835219: first-in-human study
Read More
Genor Biopharma and BioCND to develop biosimilars of Humira and Herceptin
Read More
New MR/GR agonists synthesized by Allergan
Read More
GS-444217 demonstrates efficacy in model of PAH
Read More
AQX-1125 evaluated in patients with asthma
Read More
Novel COL8A2 gene mutations found in Korean patients with FECD
Read More
Proteostasis Therapeutics receives Michael J. Fox Foundation grant
Read More
Genoa Pharmaceuticals's inhaled pirfenidone shows antifibrotic efficacy
Read More
Idera begins dosing in phase II IMO-8400 study
Read More
Receptos presents update on RPC-1063
Read More
Andromeda reports on extension study of the phase III DIA-AID1 trial
Read More
Aliskiren and VTP-27999 show different effects of on human renin and prorenin
Read More
Positive results obtained from phase III aflibercept study in mCNV
Read More
PXS-4728 as a novel SSAO inhibitor with in vivo anti-inflammatory activity
Read More
RXi Pharmaceuticals reports results from phase I RXI-109 study
Read More
CytomX and Pfizer to develop Probody-Drug Conjugates for cancer
Read More
Actelion Pharmaceuticals presents new OX1 receptor antagonists
Read More
Novel DNA topoisomerase II inhibitors patented by the University of Colorado
Read More
BioLineRx enrolls first patient in phase II BL-8040 study
Read More
Lipaglyn obtains approval in India for diabetic dyslipidemia
Read More
Sunovion Pharmaceuticals synthesizes new mu opioid receptor agonists
Read More
Novel NS5B inhibitors presented for hepatitis C virus infection
Read More
RedHill begins patient screening in phase IIa combination therapy for RRMS
Read More
Medicago reports interim data from preclinical trial of its H7N9 vaccine
Read More